Product Information
BLEOMYCIN SULFATE 15 UNIT VIAL is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $26.4480 per EA under NDC 71288010610. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
15 [USP'U]/1
Manufacturer
Meitheal Pharmaceuticals Inc.NDC
71288010610
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
BLEOMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA205030On Market Since
8/31/2018
Pharmacological Classes
Price Statistics
The NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.4480 per EA |
|---|---|
| All-time high | $31.7820 (Dec 10, 2025) |
| All-time low | $24.0040 (Dec 17, 2025) |
| 52-week high | $31.7820 |
| 52-week low | $24.0040 |
| Median price | $31.7820 |
| Average price | $29.4823 |
| Largest weekly change | -24.5% (Dec 17, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Bleomycin Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BLEOMYCIN SULFATE 15 UNIT VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BLEOMYCIN SULFATE 15 UNIT VIAL, manufactured by Meitheal Pharmaceuticals Inc., is $26.4480 per EA (NDC 71288010610), effective Jun 24, 2026.
How has the price of BLEOMYCIN SULFATE 15 UNIT VIAL changed over time?
Over the history we have for it, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has declined 16.8%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for BLEOMYCIN SULFATE 15 UNIT VIAL?
Since Dec 18, 2024, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has ranged from a low of $24.0040 (Dec 17, 2025) to a high of $31.7820 (Dec 10, 2025), with a median of $31.7820 per EA.
Are there cheaper alternatives to BLEOMYCIN SULFATE 15 UNIT VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BLEOMYCIN SULFATE 15 UNIT VIAL, so no direct lower-cost alternative is listed.
Who manufactures BLEOMYCIN SULFATE 15 UNIT VIAL?
BLEOMYCIN SULFATE 15 UNIT VIAL (NDC 71288010610) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification